These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 23805670)

  • 61. [Development of fluoroquinolone (ciprofloxacin) resistance in Mycoplasma hominis in the presence of Hela cells].
    Momynaliev KT; Smirnova OV; Ladygina VG; Orlova VF; Akopian TA; Govorun VM
    Genetika; 2002 Jul; 38(7):922-8. PubMed ID: 12174584
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of mycoplasma-contaminated continuous cell lines with mycoplasma removal agent (MRA).
    Gignac SM; Uphoff CC; MacLeod RA; Steube K; Voges M; Drexler HG
    Leuk Res; 1992 Aug; 16(8):815-22. PubMed ID: 1326687
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Kinetics of sodium dodecyl sulfate solubilization of Mycoplasma laidlawii plasma membranes.
    Auborn JJ; Eyring EM; Choules GL
    Proc Natl Acad Sci U S A; 1971 Sep; 68(9):1996-8. PubMed ID: 5289357
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Elimination of mycoplasmas from cell cultures utilizing hyperimmune sera.
    Jeansson S; Brorson JE
    Exp Cell Res; 1985 Nov; 161(1):181-8. PubMed ID: 3902490
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The effects of glucose on Mycoplasma].
    Makki S
    Z Allg Mikrobiol; 1971; 11(8):683-7. PubMed ID: 4947989
    [No Abstract]   [Full Text] [Related]  

  • 66. Mycoplasma Clearance and Risk Analysis in a Model Bioprocess.
    Wang J; Johnson S; Brown M; Lute S; Agarabi C; Dabrazhynetskaya A; Chizhikov V; Brorson K
    PDA J Pharm Sci Technol; 2017; 71(2):99-114. PubMed ID: 28089962
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development of serum-free media for the cultivation and recovery of Acholeplasma laidlawii used for challenge testing sterilizing-grade filters in biopharmaceutical applications.
    Bates S; Nguyen N; Lentine KR
    PDA J Pharm Sci Technol; 2008; 62(6):402-20. PubMed ID: 19634344
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effective treatment of mycoplasma contamination in cell lines with enrofloxacin (Baytril).
    Fleckenstein E; Uphoff CC; Drexler HG
    Leukemia; 1994 Aug; 8(8):1424-34. PubMed ID: 7520103
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A polymerase chain reaction based method for detecting Mycoplasma/Acholeplasma contaminants in cell culture.
    Tang J; Hu M; Lee S; Roblin R
    J Microbiol Methods; 2000 Jan; 39(2):121-6. PubMed ID: 10576701
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Aspiculamycin, a new cytosine nucleoside antibiotic. IV. Antimycoplasma activity of aspiculamycin in vitro and in vivo.
    Kondo F; Kitano N; Domon H; Arai M; Haneishi T
    J Antibiot (Tokyo); 1974 Jul; 27(7):529-34. PubMed ID: 4616935
    [No Abstract]   [Full Text] [Related]  

  • 71. Detection of Mycoplasma hominis septicemia by radiometric blood culture.
    Smaron MF; Boonlayangoor S; Zierdt CH
    J Clin Microbiol; 1985 Mar; 21(3):298-301. PubMed ID: 3980685
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Virus-like infectious agent (VLIA) is a novel pathogenic mycoplasma: Mycoplasma incognitus.
    Lo SC; Shih JW; Newton PB; Wong DM; Hayes MM; Benish JR; Wear DJ; Wang RY
    Am J Trop Med Hyg; 1989 Nov; 41(5):586-600. PubMed ID: 2817215
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Influence of thallium acetate on the growth of Acholeplasmataceae, Mycoplasmataceae, and some bacteria species].
    Kunze M
    Zentralbl Bakteriol Orig A; 1972 Dec; 222(4):535-9. PubMed ID: 4145172
    [No Abstract]   [Full Text] [Related]  

  • 74. Antimycoplasmal activity of hydroxytyrosol.
    Furneri PM; Piperno A; Sajia A; Bisignano G
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4892-4. PubMed ID: 15561875
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of aeration on the growth of Acholeplasma (Mycoplasma) laidlawii A.
    Virkola P
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(1):157-9. PubMed ID: 4553303
    [No Abstract]   [Full Text] [Related]  

  • 76. Eagle's basal medium as a defined medium for Mycoplasma studies.
    Quinlan DC; Liss A; Maniloff J
    Microbios; 1972; 6(22):179-85. PubMed ID: 4571002
    [No Abstract]   [Full Text] [Related]  

  • 77. Evaluation of the Etest for detection of tetracycline resistance in Mycoplasma hominis.
    Waites KB; Crabb DM; Duffy LB; Cassell GH
    Diagn Microbiol Infect Dis; 1997 Apr; 27(4):117-22. PubMed ID: 9154407
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Infection due to Mycoplasma hominis after left hip replacement: case report and literature review.
    Xiang L; Lu B
    BMC Infect Dis; 2019 Jan; 19(1):50. PubMed ID: 30642271
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro antimycoplasmal activity of mepartricin.
    Meloni GA; Busolo F; Bortolon P; Ruozi P
    Farmaco Sci; 1979 Mar; 34(3):183-8. PubMed ID: 118890
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differences in accumulation of radiolabeled amino acids and polyamines by Mycoplasma and Acholeplasma species.
    Sjöström KE; Kenny GE
    Int J Syst Bacteriol; 1990 Oct; 40(4):456-61. PubMed ID: 2275861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.